Aggressive new guidelines from the American College of Physicians (ACP)
that recommend widespread use of cholesterol-lowering statins to prevent cardiovascular
disease in patients with type 2 diabetes mellitus signal a shift from current
guidelines that base treatment on target cholesterol levels.
The guidelines, published April 20 in the Annals of
Internal Medicine, are the final product of a 3-year ACP initiative
to address the high prevalence of type 2 diabetes. Previous recommendations
focused on tight blood pressure control in patients with type 2 diabetes (Ann Intern Med. 2003;138:587-592).
Voelker R. Widespread Statin Use Recommended for Patients With Type 2 Diabetes. JAMA. 2004;291(20):2419-2420. doi:10.1001/jama.291.20.2419